Chemcon Speciality Chemicals Limited
CHEMCON.BO
Bombay Stock Exchange186.90
INR
+0.65
- -
Chemcon Speciality Chemicals Limited
CHEMCON.BO
(Bombay Stock Exchange)
Recent
price
186.90
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Chemcon Speciality Chemicals Limited manufactures and markets specialty chemicals primarily serving the pharmaceutical, agrochemical, and oilfield industries. Its core products include pharmaceutical intermediates such as hexamethyl disilazane, trimethyl chlorosilane, and bromobenzene; silanes including hexamethyl disilazane and hexamethyl disiloxane; oilfield chemicals like calcium bromide liquid and powder, sodium bromide solution, zinc bromide solution, and completion fluids used in drilling operations. The company operates with a manufacturing facility located in Vadodara, Gujarat, India, serving both domestic and international markets. Founded in 1988, Chemcon is ISO 9001 and 14001 certified and follows GMP guidelines for product quality. Recent major developments include the acquisition of Shivam Petrochem Industries’ business through a slump sale agreement valued at INR 36 crore in October 2025, expanding its operational and product capabilities. The company is also expanding its production capacity for completion fluids and launching production of Completion Dry 14.2 (Calcium Bromide powder) with a capacity of 3,500 tons annually. Chemcon continues to innovate with in-house developed processes for bromination and hydrochlorination, maintaining leadership in hexamethyldisilazane production. The company partners with leading pharmaceutical firms and emphasizes sustainability and quality to strengthen its market presence. Chemcon’s strategic focus spans pharmaceutical intermediates, oilfield chemicals, and silicone-based products, targeting pharmaceutical manufacturers, agrochemical companies, and the oil and gas sector. Financially, the company has shown stable profitability with net sales around Rs 54.89 crore in recent periods despite modest growth challenges. Its operational enhancements and recent acquisition underscore an active expansion strategy aimed at broadening its specialty chemical portfolio and geographic reach. The company continues to be headquartered in Vadodara, Gujarat, India, with a growing footprint in global specialty chemicals markets.